Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

VRCA

Insider Sentiment (TTM):

Last Purchase:2025-11-25Last Sale:2025-03-17Shares Purchased (TTM):1,485,584Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:4,776,314Shares Outstanding:21,305,025Institutional Ownership Pct.:22.42%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	11	21	30	21	15	30	46	23	32	49	70	84
Accounts Receivable Net Current	11	8	5	7	9	6	0	0	10	7	4	4
Unbilled Receivables Current	-	-	-	-	-	0	0	0	0	1	0	0
Inventory Net	3	2	2	2	3	2	2	3	3	2	1	0
Prepaid Expense And Other Assets Current	3	2	3	4	1	2	2	3	2	2	3	3
Assets Current	33	34	43	36	37	39	51	28	47	61	78	92
Property Plant And Equipment Net	0	0	0	0	0	1	1	1	1	1	1	4
Operating Lease Right Of Use Asset	0	0	1	1	1	1	1	1	1	1	1	1
Finance Lease Right Of Use Asset	-	1	1	1	1	1	1	3	3	2	1	-
Other Assets Noncurrent	1	1	0	0	0	0	0	1	0	0	0	1
Assets	36	39	47	41	39	42	54	33	52	66	82	97
Liabilities And Stockhold…
Liabilities Current
Deferred Revenue Current	-	-	-	-	0	-	-	-	-	-	-	-
Accounts Payable Current	2	2	2	2	2	1	2	1	1	3	2	2
Contract With Customer Liability Current	1	1	1	2	-	-	0	-	-	-	-	-
Long Term Debt Current	-	-	0	12	13	13	13	-	-	-	0	-
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Finance Lease Liability Current	-	0	0	0	0	0	0	1	1	1	0	0
Liabilities Current	22	16	16	29	29	29	29	21	20	19	17	11
Operating Lease Liability Noncurrent	0	0	0	0	0	1	1	1	1	1	1	1
Finance Lease Liability Noncurrent	-	1	1	1	1	1	1	2	2	2	1	0
Derivative Liabilities Noncurrent	-	-	0	2	2	2	3	-	-	-	0	-
Long Term Debt	-	-	0	22	25	28	31	43	43	43	43	42
Liabilities	32	23	22	58	57	61	64	67	65	65	62	55
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Treasury Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	352	351	350	300	299	298	297	257	255	252	250	248
Stockholders Equity Note Subscriptions Receivable	-	-	-	-	-	-	-	-	-	-0	-	-
Retained Earnings Accumulated Deficit	-348	-335	-325	-317	-317	-317	-307	-291	-268	-251	-230	-206
Stockholders Equity	4	16	25	-17	-17	-19	-10	-34	-13	2	20	42
Liabilities And Stockholders Equity	36	39	47	41	39	42	54	33	52	66	82	97
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	17	17	17	10	9	9	9	5	4	4	4	4
Shares Outstanding	17	17	17	9	9	9	9	5	4	4	4	4
Treasury Stock Common Shares	0	0	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-15.52%	-14.20%	-26.99%	-	-	-	-	-	-	-	-	-
2025	11.27%	28.55%	2.55%	-25.15%	-31.52%	-47.07%	124.17%	111.20%	78.88%	-12.62%	0.16%	-7.99%
2024	-14.44%	-20.19%	-39.23%	-38.78%	-58.01%	-50.96%	60.40%	-14.29%	-9.40%	-18.21%	-27.62%	-23.61%
2023	-	-	-	-12.48%	-26.56%	-36.29%	19.00%	128.04%	80.37%	-4.93%	32.45%	64.52%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.45	2.10	2.59	1.25	1.26	1.34	1.76	1.34	2.36	3.17	4.55	8.06
Quick Ratio	1.22	1.84	2.28	1.05	1.12	1.20	1.60	1.10	2.10	2.92	4.34	7.77
Working Capital	10.20M	17.91M	26.10M	7.37M	7.56M	10.08M	22.17M	7.16M	27.27M	42.01M	60.51M	80.35M
Leverage & Debt
Debt to Equity	7.36	1.42	0.90	-3.40	-3.24	-3.27	-6.49	-1.97	-4.91	42.97	3.13	1.30
Interest Coverage TTM	-7.60	-2.42	-1.57	-1.87	-4.28	-5.96	-7.00	-8.29	-9.35	-12.30	-16.60	-28.49
Debt Ratio	0.88	0.59	0.48	1.42	1.45	1.44	1.18	2.03	1.26	0.98	0.76	0.56
Efficiency & Turnover
Asset Turnover TTM	0.81	0.92	0.70	0.84	0.32	0.13	0.11	0.14	0.24	0.13	0.08	0.04
Days Sales Outstanding TTM	121.17	65.47	27.23	83.43	238.54	320.54	103.62	-	263.12	286.74	302.60	449.53
Receivables Turnover TTM	3.01	5.58	13.41	4.37	1.53	1.14	3.52	-	1.39	1.27	1.21	0.81
Per Share Metrics
Diluted EPS TTM	-1.46	-0.84	-1.68	-2.74	-5.12	-6.96	-14.78	-18.16	-18.69	-17.37	-14.78	-10.49
Free Cash Flow Per Share TTM	-0.79	-0.66	-1.65	-1.73	-3.66	-5.66	-11.77	-12.74	-14.18	-11.68	-8.59	-6.34
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	-	-	-	-	-	-	-	162.19%	-	-	-
Operating Profit Margin TTM	-93.59%	-37.05%	-34.25%	-53.21%	-263.42%	-772.39%	-871.25%	-843.06%	-581.38%	-866.92%	-1,283.35%	-1,524.19%
Net Profit Margin TTM	-102.84%	-47.97%	-50.27%	-84.38%	-330.52%	-919.21%	-1,012.15%	-922.81%	-625.06%	-905.83%	-1,307.47%	-1,507.90%
Growth Metrics
Net Revenue Growth (1Y)	106.21%	417.63%	370.22%	234.73%	5.72%	-19.45%	47.66%	187.45%	61.61%	3.18%	-43.27%	-64.26%
Net Income Growth (1Y)	-35.84%	-72.99%	-76.64%	-69.39%	-44.09%	-18.27%	14.31%	75.92%	271.06%	257.15%	173.59%	71.96%
EPS Growth (1Y)	-71.43%	-87.98%	-88.64%	-84.90%	-72.60%	-59.94%	0.04%	73.17%	266.39%	230.56%	106.14%	50.43%
Valuation Metrics
P/E TTM	-4.18	-6.32	-4.95	-1.57	-1.03	-0.64	-0.47	-0.80	-3.90	-3.41	-4.95	-3.70
P/B TTM	30.27	7.02	3.58	-2.40	-2.88	-2.26	-3.68	-1.99	-25.49	182.48	16.79	4.23
P/S TTM	4.30	3.03	2.49	1.33	3.42	5.84	4.79	7.37	24.37	30.87	64.77	55.87
Market Cap	130.39M	112.70M	88.52M	40.90M	50.29M	41.92M	36.27M	67.87M	339.00M	275.18M	331.91M	179.00M
Enterprise Value	119.19M	92.78M	59.42M	41.42M	59.47M	40.13M	20.92M	88.21M	349.82M	269.09M	305.23M	137.09M
Calculated Values
Free Cash Flow TTM	-16.86M	-14.11M	-17.63M	-16.42M	-34.68M	-53.68M	-60.95M	-59.62M	-65.93M	-54.29M	-38.94M	-29.23M
Net Debt	-11.20M	-19.92M	-29.10M	522.00K	9.18M	-1.79M	-15.35M	20.35M	10.82M	-6.09M	-26.67M	-41.91M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-11-25Purchase

Owner: Kirby, John J.

Title: Interim CFO

Shares: 3,536

Price/Share: $4.24

Value: $14,992.64

Shares Owned: 8,962

Relationship: Officer

Ownership: Direct

2025-11-25Purchase

Owner: Rosenberg, Noah L.

Title: CMO

Shares: 2,357

Price/Share: $4.24

Value: $9,993.68

Shares Owned: 2,357

Relationship: Officer

Ownership: Direct

2025-11-25Purchase

Owner: Manning, Paul B

Title: -

Shares: 1,375,380

Price/Share: $4.24

Value: $5,831,611.20

Shares Owned: 3,958,189

Relationship: Director,TenPercentOwner

Ownership: Direct

2025-11-25Purchase

Owner: Rieger, Jayson

Title: CEO and President

Shares: 94,311

Price/Share: $4.24

Value: $399,878.64

Shares Owned: 182,593

Relationship: Director,Officer

Ownership: Direct

2025-11-25Purchase

Owner: Zawitz, David

Title: Chief Operating Officer

Shares: 10,000

Price/Share: $4.24

Value: $42,400.00

Shares Owned: 21,000

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-11-25	Kirby, John J.	Officer	Interim CFO	Direct	Purchase	3,536	4.24	$14,992.64	8,962	4
2025-11-25	Rosenberg, Noah L.	Officer	CMO	Direct	Purchase	2,357	4.24	$9,993.68	2,357	4
2025-11-25	Manning, Paul B	Director,TenPercentOwner	-	Direct	Purchase	1,375,380	4.24	$5,831,611.20	3,958,189	4
2025-11-25	Rieger, Jayson	Director,Officer	CEO and President	Direct	Purchase	94,311	4.24	$399,878.64	182,593	4
2025-11-25	Zawitz, David	Officer	Chief Operating Officer	Direct	Purchase	10,000	4.24	$42,400.00	21,000	4
2025-03-17	Hayes, Christopher G.	Officer	CHIEF LEGAL OFFICER	Direct	Sale	4,315	0.65	$2,804.75	176,458	4
2024-11-22	Manning, Paul B	Director,TenPercentOwner	-	Direct	Purchase	18,426,966	-	-	26,278,094	4
2024-11-22	Rieger, Jayson	Director,Officer	CEO and President	Direct	Purchase	280,898	-	-	832,826	4
2024-11-22	Stalfort, John A Iii	Director	-	Direct	Purchase	1,123,595	-	-	1,823,800	4
2024-08-27	White, Ted	Director,Officer	PRESIDENT AND CEO	Direct	Sale	9,021	2.46	$22,191.66	215,967	4
2024-08-27	Hayes, Christopher G.	Officer	CHIEF LEGAL OFFICER	Direct	Sale	9,530	2.46	$23,443.80	105,773	4
2024-08-27	Goldenberg, Gary	Officer	Chief Medical Officer	Direct	Sale	3,601	2.46	$8,858.46	94,261	4
2024-08-27	Kohler, Terry	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	7,899	2.46	$19,431.54	44,697	4
2024-08-27	Bonaccorso, Joe	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	8,993	2.46	$22,122.78	73,114	4
2024-07-23	White, Ted	Director,Officer	PRESIDENT AND CEO	Direct	Sale	154	6.98	$1,074.92	249,967	4
2024-07-23	Hayes, Christopher G.	Officer	CHIEF LEGAL OFFICER	Direct	Sale	91	6.98	$635.18	141,486	4
2024-07-23	Bonaccorso, Joe	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	115	6.98	$802.70	106,816	4
2024-07-23	Goldenberg, Gary	Officer	Chief Medical Officer	Direct	Sale	86	6.98	$600.28	107,750	4
2023-12-29	Edelman, Joseph, Percepti…	TenPercentOwner	-	Indirect	Purchase	115,774	7.24	$838,203.76	7,099,182	4
2023-12-26	Perceptive, Advisors Llc,…	TenPercentOwner	-	Indirect	Purchase	54,652	6.49	$354,691.48	6,777,566	4
2023-12-19	Perceptive, Advisors Llc,…	TenPercentOwner	-	Indirect	Purchase	277,008	5.36	$1,484,762.88	6,272,914	4
2023-11-15	Kohler, Terry	Officer	Chief Financial Officer	Direct	Sale	9,632	2.97	$28,607.04	34,416	4
2023-11-15	Bonaccorso, Joe	Officer	Chief Commercial Officer	Direct	Sale	11,266	2.97	$33,460.02	92,392	4
2023-11-15	White, Ted	Director,Officer	President and CEO	Direct	Sale	11,558	2.97	$34,327.26	170,090	4
2023-11-15	Goldenberg, Gary	Officer	Chief Medical Officer	Direct	Sale	3,036	2.97	$9,016.92	86,257	4
2023-11-15	Hayes, Christopher G.	Officer	Chief Legal Officer	Direct	Sale	11,558	2.97	$34,327.26	123,226	4
2023-07-24	Goldenberg, Gary	Officer	Chief Medical Officer	Direct	Sale	28,699	4.83	$138,616.17	70,110	4
2023-07-24	Bonaccorso, Joe	Officer	Chief Commercial Officer	Direct	Sale	38,262	4.83	$184,805.46	62,738	4
2023-07-24	Hayes, Christopher G.	Officer	Chief Legal Officer	Direct	Sale	33,789	4.83	$163,200.87	81,925	4
2023-07-24	Manning, Paul B	Director,TenPercentOwner	-	Direct	Purchase	200,000	5.02	$1,004,000.00	7,851,128	4
2023-07-24	White, Ted	Director,Officer	President and CEO	Direct	Sale	50,677	4.83	$244,769.91	128,789	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

22.42%

Inst. Shares: 4,776,314

Shares Outstanding: 21,305,025

2025-12-31

48.60%

Inst. Shares: 5,177,248

Shares Outstanding: 10,652,367

2025-09-30

26.00%

Inst. Shares: 2,467,436

Shares Outstanding: 9,490,083

2025-06-30

25.99%

Inst. Shares: 2,465,699

Shares Outstanding: 9,488,055

2025-03-31

30.91%

Inst. Shares: 2,931,393

Shares Outstanding: 9,483,734

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	4,776,314	21,305,025	22.42%
2025-12-31	5,177,248	10,652,367	48.60%
2025-09-30	2,467,436	9,490,083	26.00%
2025-06-30	2,465,699	9,488,055	25.99%
2025-03-31	2,931,393	9,483,734	30.91%
2024-12-31	2,974,178	5,180,822	57.41%
2024-09-30	1,458,420	4,680,543	31.16%
2024-06-30	1,861,652	4,650,227	40.03%
2024-03-31	1,768,292	4,648,367	38.04%
2023-12-31	1,777,348	4,534,245	39.20%
2023-09-30	1,477,038	4,607,393	32.06%
2023-06-30	1,423,661	4,591,687	31.01%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Verrica Pharmaceuticals Inc. (VRCA) — SEC Financial Statements & Analysis

Verrica Pharmaceuticals Inc. (VRCA) is a pharmaceutical preparations company, incorporated in DE. Verrica Pharmaceuticals Inc. trades on Nasdaq as: VRCA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Verrica Pharmaceuticals Inc. reported a 106.21% year-over-year revenue growth, a Gross Profit Margin of 162.19% (TTM), a Debt-to-Equity ratio of 7.36x, a Price-to-Sales (P/S) ratio of 4.30x (TTM), a Price-to-Book (P/B) ratio of 30.27x (TTM), at a market cap of $130.39M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 106.21%
Gross Profit Margin TTM: 162.19%
Debt To Equity: 7.36x
P/S TTM: 4.30x
P/B TTM: 30.27x
Market Cap: $130.39M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Verrica Pharmaceuticals Inc. in?

Verrica Pharmaceuticals Inc. (VRCA) operates in the Pharmaceutical Preparations industry.

What is VRCA's market cap?

Verrica Pharmaceuticals Inc. (VRCA) has a market capitalization of $130.39M as of 2026-06-30.

What exchange does VRCA trade on?

Verrica Pharmaceuticals Inc. (VRCA) trades on the Nasdaq.

Where is Verrica Pharmaceuticals Inc. incorporated?

Verrica Pharmaceuticals Inc. is incorporated in DE.